Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Mesenchymal Stem Cell Conditioned Medium for Allergic Disorders
jRCT1051230176Recruiting
- Sponsor
- Nagamine Medical Clinic Ginza
- Start
- Jan 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial in allergy, allergic rhinitis (AR) and atopic dermatitis (AD), sponsored by Nagamine Medical Clinic Ginza. Primary endpoint: Self-reported allergy symptoms. Started Jan 2024; status: recruiting.
02
Conditions
allergyallergic rhinitis (AR)atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT1051230176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051230176.